dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
survanta intratracheal 8ml vial
سيرفانتا فيال 8 مل
beractant
4064EGP
Available
Active ingredient
beractant
Form
vial
Manufacturer
abbvie ltd.
Route
injection

Uses

Used for prevention and treatment of respiratory distress syndrome in premature infants.

Do not use if

No specific contraindications are established in the labeling.

Side effects

Common adverse effects include transient bradycardia, oxygen desaturation, and airway obstruction during administration.

Warnings

Should only be administered in highly supervised neonatal intensive care settings by experienced clinicians.

How it works

Pulmonary surfactant replacement therapy that reduces alveolar surface tension and improves lung function.

Storage

Store according to manufacturer recommendations and maintain cold-chain requirements.